跳至主要内容
临床试验/NL-OMON22707
NL-OMON22707尚未招募不适用

Women’s Hormonal Intervention Study in early Postmenopause of Estradiol-progesterone Replacement therapy - effects on quality of life.

Besins Healthcare0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Postmenopausal women: last menstrual period between 6 months and maximum 5 years ago, FSH levels > 35 IU/L and estradiol levels < 20 picograms/mL (cut offs defined by central laboratory: Klinisch Chemisch Laboratorium” at MUMC);
  • 2. Positive progesterone challenge test;

排除标准

  • 1. Previous use of any hormone replacement therapy for a duration of more than 3 years;
  • 2. Use of medication known to interact with 17 ß-estradiol or micronized progesterone;
  • - Substances known to induce drug-metabolising enzymes, particularly anticonvulsants (e.g. phenobarbital, phenytoin, carbamazepine) and anti-infectives (e.g. rifampicin, fifabutin, nevirapine, efavirenz):

研究者

发起方
Besins Healthcare

相似试验